Email updates

Keep up to date with the latest news and content from Molecular Pain and BioMed Central.

Open Access Open Badges Short report

Compound heterozygosity in sodium channel Nav1.7 in a family with hereditary erythermalgia

Mark E Samuels14*, Rene HM te Morsche2, Mary E Lynch3 and Joost PH Drenth2

Author Affiliations

1 Département de Médicine, Centre de Recherche du CHUM, Local M-5226, Hôpital Notre-Dame, 1560 rue Sherbrooke Est, Montréal QC H2L 4M1, Canada

2 Department of Medicine, Division of Gastroenterology, University Medical Center St. Radboud, PO Box 9101, 6500 HB Nijmegen, The Netherlands

3 Departments of Psychiatry, Anesthesia and Pharmacology, Victoria General 10 West Victoria, 1278 Tower Road, Dalhousie University, Halifax NS B3H 2Y9, Canada

4 Current address : A-733, Centre de Recherche du CHU Ste-Justine 3175, Cote Ste-Catherine Montreal, QC H3T 1C5 Canada

For all author emails, please log on.

Molecular Pain 2008, 4:21  doi:10.1186/1744-8069-4-21

Published: 2 June 2008


Hereditary erythermalgia is a painful and debilitating genetic disorder associated with mutations in voltage-gated sodium channel Nav1.7. We have previously reported a Canadian family segregating erythermalgia consistently with a dominant genetic etiology. Molecular analysis of the proband from the family detected two different missense mutations in Nav1.7. In the present study we have performed a long-term follow-up clinical study of disease progression in three affected family members. A more extensive molecular study has also been completed, analyzing the segregation of the two missense variants in the family. The two variants (P610T, L858F) segregate independently with respect to clinical presentation. Detailed genotype/phenotype correlation suggests that one of the two variants (L858F) is causal for erythermalgia. The second variant (P610T) may modify the phenotype in the proband. This is the second reported study of potential compound heterozygosity for coding polymorphisms in Nav1.7, the first being in a patient with paroxysmal extreme pain disorder.